VEGF Receptor Blockade Markedly Reduces Retinal Microglia/Macrophage Infiltration into Laser-Induced CNV

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Huang, Hu ^a   Parlier, Rachel ^a   Shen, Ji kui ^a   Lutty, Gerard A ^a   Vinores, Stanley A ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD11B ANTIGEN; CD45 ANTIGEN; CHEMOKINE RECEPTOR CX3CR1; LECTIN; MESSENGER RNA; MINOCYCLINE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY DC101; MONOCLONAL ANTIBODY MF1; NEUTRALIZING ANTIBODY; PLACENTAL GROWTH FACTOR; UNCLASSIFIED DRUG; VASCULOTROPIN A; VASCULOTROPIN B; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL INFILTRATION; CELL MIGRATION; CONTROLLED STUDY; DRUG ACTIVITY; IMMUNOFLUORESCENCE; IN VIVO STUDY; LASER SURGERY; LEUKOCYTE COUNT; MACROPHAGE; MICRODISSECTION; MICROGLIA; MOUSE; NONHUMAN; PATHOPHYSIOLOGY; PIGMENT EPITHELIUM; PROTEIN EXPRESSION; PROTEIN FUNCTION; RETINA; RETINA MACULA AGE RELATED DEGENERATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SUBRETINAL NEOVASCULARIZATION;

ANIMALS; ANTIBODIES, MONOCLONAL, MURINE-DERIVED; CELL MOVEMENT; CHOROIDAL NEOVASCULARIZATION; DISEASE MODELS, ANIMAL; HUMANS; INJECTIONS, INTRAPERITONEAL; LASER CAPTURE MICRODISSECTION; LASERS; MACROPHAGES; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; MICROGLIA; MINOCYCLINE; RETINA; TISSUE CULTURE TECHNIQUES; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-1; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2; WET MACULAR DEGENERATION;

EID: 84882586316     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071808     Document Type: Article

References (52)

1. Nowak JZ, (2006) Age-related macular degeneration (AMD): pathogenesis and therapy. Pharmacol Rep 58: 353-363.
2. Campochiaro PA, Soloway P, Ryan SJ, Miller JW, (1999) The pathogenesis of choroidal neovascularization in patients with age-related macular degeneration. Mol Vis 5: 34.
3. Campa C, Costagliola C, Incorvaia C, Sheridan C, Semeraro F, et al. (2010) Inflammatory mediators and angiogenic factors in choroidal neovascularization: pathogenetic interactions and therapeutic implications. Mediators Inflamm 2010.
4. Sepp T, Khan JC, Thurlby DA, Shahid H, Clayton DG, et al. (2006) Complement factor H variant Y402H is a major risk determinant for geographic atrophy and choroidal neovascularization in smokers and nonsmokers. Invest Ophthalmol Vis Sci 47: 536-540.
5. Suner IJ, Espinosa-Heidmann DG, Marin-Castano ME, Hernandez EP, Pereira-Simon S, et al. (2004) Nicotine increases size and severity of experimental choroidal neovascularization. Invest Ophthalmol Vis Sci 45: 311-317.
6. Hogg RE, Woodside JV, Gilchrist SE, Graydon R, Fletcher AE, et al. (2008) Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology 115: 1046-1052 e1042.
7. Liutkeviciene R, Lesauskaite V, Asmoniene V, Zaliuniene D, Jasinskas V, (2010) Factors determining age-related macular degeneration: a current view. Medicina (Kaunas) 46: 89-94.
8. Cao J, Zhao L, Li Y, Liu Y, Xiao W, et al. (2010) A subretinal matrigel rat choroidal neovascularization (CNV) model and inhibition of CNV and associated inflammation and fibrosis by VEGF trap. Invest Ophthalmol Vis Sci 51: 6009-6017.
9. Lyzogubov VV, Tytarenko RG, Liu J, Bora NS, Bora PS, (2011) Polyethylene glycol (PEG)-induced mouse model of choroidal neovascularization. J Biol Chem 286: 16229-16237.
10. Baba T, Bhutto IA, Merges C, Grebe R, Emmert D, et al. (2010) A rat model for choroidal neovascularization using subretinal lipid hydroperoxide injection. Am J Pathol 176: 3085-3097.
11. Tobe T, Ortega S, Luna JD, Ozaki H, Okamoto N, et al. (1998) Targeted disruption of the FGF2 gene does not prevent choroidal neovascularization in a murine model. Am J Pathol 153: 1641-1646.
12. Edelman JL, Castro MR, (2000) Quantitative image analysis of laser-induced choroidal neovascularization in rat. Exp Eye Res 71: 523-533.
13. Montezuma SR, Vavvas D, Miller JW, (2009) Review of the ocular angiogenesis animal models. Semin Ophthalmol 24: 52-61.
14. Vinores SA, Xiao WH, Aslam S, Shen J, Oshima Y, et al. (2006) Implication of the hypoxia response element of the Vegf promoter in mouse models of retinal and choroidal neovascularization, but not retinal vascular development. J Cell Physiol 206: 749-758.
15. Sengupta N, Caballero S, Mames RN, Butler JM, Scott EW, et al. (2003) The role of adult bone marrow-derived stem cells in choroidal neovascularization. Invest Ophthalmol Vis Sci 44: 4908-4913.
16. Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, et al. (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178-190.
17. Kwak N, Okamoto N, Wood JM, Campochiaro PA, (2000) VEGF is major stimulator in model of choroidal neovascularization. Invest Ophthalmol Vis Sci 41: 3158-3164.
18. Huang H, Shen J, Vinores SA, (2011) Blockade of VEGFR1 and 2 suppresses pathological angiogenesis and vascular leakage in the eye. PLoS One 6: e21411.
19. Hou X, Kumar A, Lee C, Wang B, Arjunan P, et al. (2010) PDGF-CC blockade inhibits pathological angiogenesis by acting on multiple cellular and molecular targets. Proc Natl Acad Sci U S A 107: 12216-12221.
20. Kumar A, Hou X, Lee C, Li Y, Maminishkis A, et al. (2010) Platelet-derived growth factor-DD targeting arrests pathological angiogenesis by modulating glycogen synthase kinase-3beta phosphorylation. J Biol Chem 285: 15500-15510.
21. Fu Y, Ponce ML, Thill M, Yuan P, Wang NS, et al. (2007) Angiogenesis inhibition and choroidal neovascularization suppression by sustained delivery of an integrin antagonist, EMD478761. Invest Ophthalmol Vis Sci 48: 5184-5190.
22. Berglin L, Sarman S, van der Ploeg I, Steen B, Ming Y, et al. (2003) Reduced choroidal neovascular membrane formation in matrix metalloproteinase-2-deficient mice. Invest Ophthalmol Vis Sci 44: 403-408.
23. Lambert V, Munaut C, Jost M, Noel A, Werb Z, et al. (2002) Matrix metalloproteinase-9 contributes to choroidal neovascularization. Am J Pathol 161: 1247-1253.
24. Kleinman ME, Yamada K, Takeda A, Chandrasekaran V, Nozaki M, et al. (2008) Sequence- and target-independent angiogenesis suppression by siRNA via TLR3. Nature 452: 591-597.
25. Luhmann UF, Robbie S, Munro PM, Barker SE, Duran Y, et al. (2009) The drusenlike phenotype in aging Ccl2-knockout mice is caused by an accelerated accumulation of swollen autofluorescent subretinal macrophages. Invest Ophthalmol Vis Sci 50: 5934-5943.26.
26. Caicedo A, Espinosa-Heidmann DG, Pina Y, Hernandez EP, Cousins SW, (2005) Blood-derived macrophages infiltrate the retina and activate Muller glial cells under experimental choroidal neovascularization. Exp Eye Res 81: 38-47.
27. Ambati J, Anand A, Fernandez S, Sakurai E, Lynn BC, et al. (2003) An animal model of age-related macular degeneration in senescent Ccl-2- or Ccr-2-deficient mice. Nat Med 9: 1390-1397.
28. Lyzogubov VV, Tytarenko RG, Jha P, Liu J, Bora NS, et al. (2010) Role of ocular complement factor H in a murine model of choroidal neovascularization. Am J Pathol 177: 1870-1880.
29. Combadiere C, Feumi C, Raoul W, Keller N, Rodero M, et al. (2007) CX3CR1-dependent subretinal microglia cell accumulation is associated with cardinal features of age-related macular degeneration. J Clin Invest 117: 2920-2928.
30. Ma W, Zhao L, Fontainhas AM, Fariss RN, Wong WT, (2009) Microglia in the mouse retina alter the structure and function of retinal pigmented epithelial cells: a potential cellular interaction relevant to AMD. PLoS One 4: e7945.
31. Rymo SF, Gerhardt H, Wolfhagen Sand F, Lang R, Uv A, et al. (2011) A two-way communication between microglial cells and angiogenic sprouts regulates angiogenesis in aortic ring cultures. PLoS One 6: e15846.
32. Semkova I, Muether PS, Kuebbeler M, Meyer KL, Kociok N, et al. (2011) Recruitment of blood-derived inflammatory cells mediated via tumor necrosis factor-alpha receptor 1b exacerbates choroidal neovascularization. Invest Ophthalmol Vis Sci 52: 6101-6108.
33. Lavalette S, Raoul W, Houssier M, Camelo S, Levy O, et al. (2011) Interleukin-1beta inhibition prevents choroidal neovascularization and does not exacerbate photoreceptor degeneration. Am J Pathol 178: 2416-2423.
34. Huang H, Van de Veire S, Dalal M, Parlier R, Semba RD, et al. (2011) Reduced retinal neovascularization, vascular permeability, and apoptosis in ischemic retinopathy in the absence of prolyl hydroxylase-1 due to the prevention of hyperoxia-induced vascular obliteration. Invest Ophthalmol Vis Sci 52: 7565-7573.
35. Sengupta N, Afzal A, Caballero S, Chang KH, Shaw LC, et al. (2010) Paracrine modulation of CXCR4 by IGF-1 and VEGF: implications for choroidal neovascularization. Invest Ophthalmol Vis Sci 51: 2697-2704.
36. Guerin E, Sheridan C, Assheton D, Kent D, Wong D, et al. (2008) SDF1-alpha is associated with VEGFR-2 in human choroidal neovascularisation. Microvasc Res 75: 302-307.
37. Van de Veire S, Stalmans I, Heindryckx F, Oura H, Tijeras-Raballand A, et al. (2010) Further pharmacological and genetic evidence for the efficacy of PlGF inhibition in cancer and eye disease. Cell 141: 178-190.
38. Ryu JK, Cho T, Choi HB, Wang YT, McLarnon JG, (2009) Microglial VEGF receptor response is an integral chemotactic component in Alzheimer's disease pathology. J Neurosci 29: 3-13.
39. Luttun A, Tjwa M, Moons L, Wu Y, Angelillo-Scherrer A, et al. (2002) Revascularization of ischemic tissues by PlGF treatment, and inhibition of tumor angiogenesis, arthritis and atherosclerosis by anti-Flt1. Nat Med 8: 831-840.40.
40. Waters JC, (2009) Accuracy and precision in quantitative fluorescence microscopy. J Cell Biol 185: 1135-1148.
41. Campa C, Kasman I, Ye W, Lee WP, Fuh G, et al. (2008) Effects of an anti-VEGF-A monoclonal antibody on laser-induced choroidal neovascularization in mice: optimizing methods to quantify vascular changes. Invest Ophthalmol Vis Sci 49: 1178-1183.
42. Wahlin KJ, Moreira EF, Huang H, Yu N, Adler R, (2008) Molecular dynamics of photoreceptor synapse formation in the developing chick retina. J Comp Neurol 506: 822-837.
43. Santos AM, Calvente R, Tassi M, Carrasco MC, Martin-Oliva D, et al. (2008) Embryonic and postnatal development of microglial cells in the mouse retina. J Comp Neurol 506: 224-239.
44. Lee JE, Liang KJ, Fariss RN, Wong WT, (2008) Ex vivo dynamic imaging of retinal microglia using time-lapse confocal microscopy. Invest Ophthalmol Vis Sci 49: 4169-4176.
45. Wang AL, Yu AC, Lau LT, Lee C, Wu le M, et al. (2005) Minocycline inhibits LPS-induced retinal microglia activation. Neurochem Int 47: 152-158.
46. Gupta N, Brown KE, Milam AH, (2003) Activated microglia in human retinitis pigmentosa, late-onset retinal degeneration, and age-related macular degeneration. Exp Eye Res 76: 463-471.
47. Barleon B, Sozzani S, Zhou D, Weich HA, Mantovani A, et al. (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87: 3336-3343.
48. Liu J, Jha P, Lyzogubov VV, Tytarenko RG, Bora NS, et al. (2011) Relationship between complement membrane attack complex, chemokine (C-C motif) ligand 2 (CCL2) and vascular endothelial growth factor in mouse model of laser-induced choroidal neovascularization. J Biol Chem 286: 20991-21001.
49. Yi X, Ogata N, Komada M, Yamamoto C, Takahashi K, et al. (1997) Vascular endothelial growth factor expression in choroidal neovascularization in rats. Graefes Arch Clin Exp Ophthalmol 235: 313-319.
50. Hu W, Criswell MH, Fong SL, Temm CJ, Rajashekhar G, et al. (2009) Differences in the temporal expression of regulatory growth factors during choroidal neovascular development. Exp Eye Res 88: 79-91.
51. Wilson AS, Hobbs BG, Shen WY, Speed TP, Schmidt U, et al. (2003) Argon laser photocoagulation-induced modification of gene expression in the retina. Invest Ophthalmol Vis Sci 44: 1426-1434.
52. Mochimaru H, Takahashi E, Tsukamoto N, Miyazaki J, Yaguchi T, et al. (2009) Involvement of hyaluronan and its receptor CD44 with choroidal neovascularization. Invest Ophthalmol Vis Sci 50: 4410-4415.